报价延迟最少15分钟:2026/02/28 16:50 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.6 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.13/-0.15
|
|
企业价值
112.56M
|
| 资产负债 |
|
每股账面净值
0.02
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis. |
